C21 Investments (TSE:CXXI) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
C21 Investments reported a strong second quarter, with revenue growing 14% to $7.5 million, driven by the successful launch of their new South Reno dispensary. The company achieved a notable increase in gross margin to 43.5%, up from 31% in the previous quarter, and improved adjusted EBITDA to $1.3 million from $0.3 million in Q1. Despite a net loss of $0.8 million primarily due to tax expenses, C21’s strategic expansion efforts are demonstrating promising growth and operational efficiencies.
For further insights into TSE:CXXI stock, check out TipRanks’ Stock Analysis page.